Long-term increase in serum cholesterol levels in ulcerative colitis patients treated with cyclosporine: an underdiagnosed side effect frequently associated with other drug-related complications

References

• Holme O, Thiis-Evensen E, Vatn MH. Treatment of fulminant ulcerative colitis with cyclosporine A. Scand J Gastroenterol 2009;44:1310–14.
   PubMed Web of Science ®Google Scholar
• Travis SP, Stange EF, Lémann M, Oresland T, Bemelman WA, Chowers Y, et al. European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis 2008;2:24–62.
   PubMed Web of Science ®Google Scholar
• Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, et al. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet 2012;380:1909–15.
   PubMed Web of Science ®Google Scholar
• Chang KH, Burke JP, Coffey JC. Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis. Int J Colorectal Dis 2013;28:287–93.
   PubMed Web of Science ®Google Scholar
• Cheifetz A, Stern J, Garud S, Goldstein E, Malter L, Moss AC, et al. Cyclosporine is Safe and Effective in Patients With Severe Ulcerative Colitis. J Clin Gastroenterol 2011;45:107–12.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Naganuma M, Okamoto S, Hisamatsu T, Inoue N, Ichikawa H, et al. Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis. J Gastroenterol 2010;45:1129–37.
   PubMed Web of Science ®Google Scholar
• Durai D, Hawthorne AB. Review article: how and when to use ciclosporine in ulcerative colitis. Aliment Pharmacol Ther 2005;22:907–16.
   PubMed Web of Science ®Google Scholar
• Maza A, Montaudié H, Sbidian E, Gallini A, Aractingi S, Aubin F, et al. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. J Eur Acad Dermatol Venereol 2011;25:19–27.
   PubMed Web of Science ®Google Scholar
• Ballantyne CM, Podet EJ, Patsch WP, Harati Y, Appel V, Gotto AM Jr, et al. Effects of Cyclosporine Therapy on Plasma Lipoprotein Levels. JAMA 1989;262:53–6.
   PubMed Web of Science ®Google Scholar
• Cohen RD, Brodsky AL, Hanauer SB. A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin. Inflamm Bowel Dis 1999;5:1–10.
   PubMed Web of Science ®Google Scholar
• Van Assche G, D'Haens G, Noman M, Vermeire S, Hiele M, Asnong K, et al. Randomized, Double-Blind Comparison of 4 mg/kg Versus 2 mg/kg Intravenous Cyclosporine in Severe Ulcerative Colitis. Gastroenterology 2003;125:1025–31.
   PubMed Web of Science ®Google Scholar
• Siew C Ng, Kamm MA. Therapeutic Strategies for the management of ulcerative colitis. Inflamm Bowel Dis 2009;15:935–50.
   PubMed Web of Science ®Google Scholar
• Gomollón F, García-López S, Sicilia B, Gisbert JP, Hinojosa J; GETECCU. The GETECCU clinical guideline for the treatment of ulcerative colitis: A guideline created using GRADE methodology. Gastroenterol Hepatol; Article in press.
   Web of Science ®Google Scholar
• Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N EnglJMed 1994;30:1841–5.
   Google Scholar
• Weber A, Fein F, Koch S, Dupont-Gossart AC, Mantion G, Heyd B, et al. Treatment of Ulcerative Colitis Refractory to Steroid Therapy by Oral Microemulsion Cyclosporine (Neoral). Inflamm Bowel Dis 2006;12:1131–5.
   PubMed Web of Science ®Google Scholar
• Kuster GM, Drexel H, Bleisch JA, Rentsch K, Pei P, Binswanger U, et al. Relation of cyclosporine blood levels to adverse effects on lipoproteins. Transplantation 1994;57:1479–83.
   PubMed Web of Science ®Google Scholar
• Reed RM, Hashmi S, Eberlein M, Iacono A, Netzer G, DeFilippis A, et al. Impact of lung transplantation on serum lipids in COPD. Respir Med 2011;105:1961–8.
   PubMed Web of Science ®Google Scholar
• Ragheb A, Attia A, Elbarbry F, Prasad K, Shoker A. Attenuated Combined Action of Cyclosporine A and Hyperlipidemia on Atherogenesis in Rabbits by Thymoquinone. Evid Based Complement Alternat Med 2011.
   PubMed Web of Science ®Google Scholar
• Spinelli GA, Felipe CR, park SI, Mandia-Sampaio EL, Tedesco-Silva H Jr, Madina-Pestana JO. Lipid Profile Changes During the First Year After Kidney Transplantation: Risk Factrors and Influence of the Immunosuppressive Drug Regimen. Transplant Proc 2011;43:3730–7.
   PubMed Web of Science ®Google Scholar
• Azer SA, Stacey NH. Differential effects of cyclosporin A on the transport of bile acids by human hepatocytes. Biochem Pharmacol 1993;45:813–19.
   Google Scholar
• Hulzebos VC, Bijleveld CM, Stellaard F, Fidler V, Slooff MJ, Peeters PM, et al. Cyclosporine A–induced reduction of bile salt synthesis associated with increased plasma lipids in children after liver transplantation. Liver Transpl 2004;10:872–80.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang ZR, Chou CF, Liang YY, Gu Y, Ma HP. Cyclosporine stimulated the renal epithel sodium channel by elevating cholesterol. Am J Physiol Renal Physiol 2009;296:284–90.
   Web of Science ®Google Scholar
• Zheng XL, Wong NCW. Cyclosporin A inhibits apolipoprotein AI gene expression. J Mol Endocrinol 2006;37:367–73.
   PubMed Web of Science ®Google Scholar
• Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, et al. Utility of different lipid measuresfor prediction of coronary heart disease in men and women. JAMA 2007;298:776–85; Reprinted.
   PubMed Web of Science ®Google Scholar
• Suk HY, Zhou C, Yang TT, Zhu H, Yu RY, Olabisi O, et al. Ablation of calcineurin Aβ reveals hyperlipidemia and signaling crosstalks with phosphodiesterases. J Biol Chem 2012; Epub ahead of print.
   Web of Science ®Google Scholar
• Charco RR, Cantarell C, Vargas V, Capdevila L, Lazaro JL, Hidalgo E, et al. Serum cholesterol changes in long-term survivors of liver transplantation:A comparison between cyclosporine and tacrolimus therapy. Liver Transpl Surg 1999;5:204–8.
   PubMedGoogle Scholar